Exair® Versus Native Tissue Repair for Prolapse

NCT02162628 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 79

Last updated 2015-12-14

No results posted yet for this study

Summary

The purpose of this study is to compare safety and effectiveness of the Exair Prolapse Repair System for treatment of pelvic organ prolapse to traditional native tissue repair through 36 months of follow-up.

Conditions

  • Pelvic Organ Prolapse

Interventions

DEVICE

Exair Prolapse Repair System

PROCEDURE

Total Native Tissue Repair

Sponsors & Collaborators

  • Coloplast A/S

    lead INDUSTRY

Principal Investigators

  • James Lukban, DO, FACOG · The Pelvic Solutions Center

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02162628 on ClinicalTrials.gov